Antigoni Lekka

Serum resistin: A biomarker of breast cancer in postmenopausal women? Association with clinicopathological characteristics, tumor markers, inflammatory and metabolic parameters

Μaria Dalamaga, George Sotiropoulos, Nicolaos Pelekanos et al. · Clinical Biochemistry · 2013 · 110 citations

Biomarker (Medicine), Breast Oncology, Oncology +9

Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case–control study

Μaria Dalamaga, A. Panagiotou, Alex Hsi et al. · Cancer Causes & Control · 2008 · 110 citations

Metabolic Syndrome, Medicine, Case–control Study +6

Elevated serum visfatin/nicotinamide phosphoribosyl-transferase levels are associated with risk of postmenopausal breast cancer independently from adiponectin, leptin, and anthropometric and metabolic parameters

Μaria Dalamaga, Evangelia Papadavid, Nicolaos Pelekanos et al. · Menopause The Journal of The North American Menopause Society · 2011 · 77 citations

Could serum visfatin be a potential biomarker for postmenopausal breast cancer?

Μaria Dalamaga, Stavros Archondakis, George Sotiropoulos et al. · Maturitas · 2012 · 62 citations

Biomarker (Medicine), Postmenopausal Breast Cancer, Breast Oncology +13

Hyperresistinemia is associated with postmenopausal breast cancer

Μaria Dalamaga, Evangelia Papadavid, Nicolaos Pelekanos et al. · Menopause The Journal of The North American Menopause Society · 2013 · 61 citations